Prof Xavier Carcopino is an expert in Gynecology at Hôpital Nord (France). Xavier Carcopino has authored 208 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 573 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Xavier Carcopino Hôpital Nord France
573 ScienceLeadR Reputation 573
Network Map

Gynecology

Subspecialties: Obstetrics - Oncology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Hôpital de la Conception

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Special situations in cervical cancer management: de novo metastatic disease, occult cancer after simple hysterectomy, and cervical stump cancer - A review from the french cervical cancer guidelines group.
PMID 42946053 — radiotherapy, hysterectomy, uterine cervical neoplasms, brachytherapy, neoplasms, immunotherapy, gynecology, therapeutics
J Gynecol Obstet Hum Reprod20260
CERVICAL CANCER: NATIONAL CLINICAL PRACTICE GUIDELINES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
PMID 42946055 — radiotherapy, conization, uterine cervical neoplasms, brachytherapy, neoplasms, gynecology, therapeutics
J Gynecol Obstet Hum Reprod20260
FERTILITY-SPARING SURGERY AND OVARIAN TRANSPOSITION IN CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
PMID 42946052 — radiotherapy, fertility, trachelectomy, safety, conization, hysterectomy, uterine cervical neoplasms, ovary, neoplasms, lymph, gynecology, therapeutics
J Gynecol Obstet Hum Reprod20260
Risk-Adapted surgical treatment of early-stage cervical cancer: tailoring radicality, ovarian preservation, and surgical approach in the post-shape and post-lacc era - A review from the french cervical cancer guidelines group.
PMID 42946054 — hysterectomy, uterine cervical neoplasms, ovary, neoplasms, lymph, gynecology, morbidity, therapeutics
J Gynecol Obstet Hum Reprod20260
Predictive factors for the absence of high-grade intraepithelial lesions in LLETZ specimens following a prior histological diagnosis.
PMID 42316784 — absenteeism, obstetrics, cell biology, gynecology, diagnosis, colposcopy, wounds and injuries, cervix uteri, cytology
Acta Obstet Gynecol Scand20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 7

By status:

Completed 3
Active not recruiting 1
Not yet recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 7

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 2
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients
NCT06647849 — pregnancy, pregnancy trimester, first, emergencies, multicenter studies as topic, stress, physiological, abortion, spontaneous, simulation training, diagnosis, emergency service, hospital, gynecologists, obstetricians, women
N/AActive not recruiting2024

LeadR Networks

Main global connection map